rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
1992-4-15
|
pubmed:abstractText |
Pneumocystis carinii pneumonia (PCP) is a major cause of morbidity and the leading cause of death in patients with the acquired immunodeficiency syndrome. The prevention of the occurrence and recurrence of PCP is a cornerstone in the treatment of patients infected with the human immunodeficiency virus. There are few studies comparing PCP prophylactic regimens.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0003-9926
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
152
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
523-8
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:1546914-Acquired Immunodeficiency Syndrome,
pubmed-meshheading:1546914-Adult,
pubmed-meshheading:1546914-Aged,
pubmed-meshheading:1546914-Dapsone,
pubmed-meshheading:1546914-Drug Administration Schedule,
pubmed-meshheading:1546914-Drug Therapy, Combination,
pubmed-meshheading:1546914-Female,
pubmed-meshheading:1546914-Humans,
pubmed-meshheading:1546914-Male,
pubmed-meshheading:1546914-Middle Aged,
pubmed-meshheading:1546914-Pentamidine,
pubmed-meshheading:1546914-Pneumonia, Pneumocystis,
pubmed-meshheading:1546914-Recurrence,
pubmed-meshheading:1546914-Retrospective Studies,
pubmed-meshheading:1546914-Trimethoprim-Sulfamethoxazole Combination,
pubmed-meshheading:1546914-Zidovudine
|
pubmed:year |
1992
|
pubmed:articleTitle |
A comparison of the effectiveness of three regimens in the prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients.
|
pubmed:affiliation |
Department of Medicine, Harbor-UCLA Medical Center, Torrance.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|